Camostat mesylate restores intestinal barrier integrity and attenuated protein loss in experimental protein-losing enteropathy.
Saved in:
| Title: | Camostat mesylate restores intestinal barrier integrity and attenuated protein loss in experimental protein-losing enteropathy. |
|---|---|
| Authors: | Lee J; Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, South Korea., Cho CS; Fight Against Angiogenesis-Related Blindness (FARB) Laboratory, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea., Jeong HC; Fight Against Angiogenesis-Related Blindness (FARB) Laboratory, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea., Kim JH; Fight Against Angiogenesis-Related Blindness (FARB) Laboratory, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea; Department of Ophthalmology, Seoul National University College of Medicine, Seoul, South Korea., Hyun Jo D; Department of Anatomy and Cell Biology, Seoul National University College of Medicine, Seoul, South Korea. Electronic address: lawrenc2@snu.ac.kr., Kim GB; Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, South Korea. Electronic address: ped9526@snu.ac.kr. |
| Source: | Biochemical pharmacology [Biochem Pharmacol] 2026 Jan; Vol. 243 (Pt 2), pp. 117555. Date of Electronic Publication: 2025 Nov 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2968 (Electronic) Linking ISSN: 00062952 NLM ISO Abbreviation: Biochem Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
